Apyx Medical is an energy technology company. In its Advanced Energy segment, Co.'s product portfolio consists of its Helium Plasma Technology that is marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Co.'s primary focus is on the cosmetic surgery market where Renuvion® provides plastic surgeons, facial plastic surgeons and cosmetic physicians an ability to provide controlled heat to the tissue. In its Original Equipment Manufacturing (OEM) segment, Co. produces generators and related accessories for medical device manufacturers through OEM agreements, as well as start-up companies with the need for its energy-based designs. The APYX stock yearly return is shown above.
The yearly return on the APYX stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2023 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the APYX annual return calculation with any dividends reinvested as applicable (on ex-dates).
|